Clinical trial
Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury
NCT07166393 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury
- Lead sponsor
- Northwestern University
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- May 31, 2027
- Completion date
- December 31, 2031
- Enrollment
- 432 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
moderate traumatic brain injury (tbi), severe traumatic brain injury